| |
Evera Medical Seeks Financing For Aesthetic Devices
July 25, 2008 - Brian Gormley, VentureWire
FDA Grants Approval to Evera Medical's FulFil Lip IDE Application
FOSTER CITY, CA, August 12, 2008 /PRNewswire/ -- Evera Medical announced today that the U.S. Food and Drug Administration has granted conditional approval of the Company's investigational device exemption (IDE) application for its
FulFil Lip cosmetic augmentation implant.
Evera Medical Announces the Two-Year Mark Since the First Treatment With its Saline-Filled Facial Implant
FOSTER CITY, CA, October 29, 2007 /PRNewswire/ -- Evera Medical, a medical device company that commercializes small, saline-adjustable facial implants for a range of indications, today announced it has been two years since the first patient was treated. No serious adverse events have been reported.
Evera Medical Receives CE Mark for Novel Lip Implant
FOSTER CITY, CA, April 20, 2007 /PRNewswire/ -- Evera Medical, maker of FulFil(TM), a novel saline-filled implant for tissue augmentation, today announced that the company has been granted the CE Mark, allowing the company to market its FulFil implant throughout the European Union, and that the first UK patient was treated by
Dr. Lucy Glancey.
Public Relations Contact Information
Public Relations
Tel: 650.287.2880
media@everamedical.com
|
|
 |
